It's all in the timing

Blood

Volumn 118, Issue 23, 2011, Pages 5983-5984

  Bendall, Linda J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CHECKPOINT KINASE 2; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; MAFOSFAMIDE; METHOTREXATE; MRE11 PROTEIN; PREDNISOLONE; PROTEIN P53; VINCA ALKALOID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ATAXIA TELANGIECTASIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; DNA DAMAGE; DRUG ANTAGONISM; DRUG EXPOSURE; DRUG MECHANISM; DRUG SCREENING; HEMATOLOGIC MALIGNANCY; HUMAN; NOTE; PRIORITY JOURNAL; PUBLISHING; TREATMENT RESPONSE;

EID: 83055161523     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-381111     Document Type: Note

References (8)

1. Ehrhardt H, Schrembs D, Moritz C, et al. Optimized anti-tumor effects of anthracyclines plus vinca alkaloids using a novel, mechanism-based application schedule. Blood. 2011;118(23):6123-6131.
2. Ling YH, el-Naggar AK, Priebe W, Perez-Soler R. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol. 1996;49(5):832-841.
3. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74(6):957-967. (Pubitemid 23289454)
4. Kawamura KI, Grabowski D, Weizer K, Bukowski R, Ganapathi R. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells. Br J Cancer. 1996;73(2):183-188.
5. Akutsu M, Furukawa Y, Tsunoda S, Izumi T, Ohmine K, Kano Y. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro. Leukemia. 2002;16(9):1808-1817.
6. Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk I, Hahlen K, Van Wering ER. Drug combination testing in acute lymphoblastic leukemia using theMTTassay. Leuk Res. 1995;19(3):175-181.
7. Ham MF, Takakuwa T, Luo WJ, Liu A, Horii A, Aozasa K. Impairment of double-strand breaks repair and aberrant splicing ofATMand MRE11 in leukemia-lymphoma cell lines with microsatellite instability. Cancer Sci. 2006;97(3):226-234.
8. Havranek O, Spacek M, Hubacek P, et al. Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma. Neoplasma. 2011;58(5):392-395.